Carlson College of Veterinary Medicine

G. F. Callanan, Curran, K. M., Parachini-Winter, C., Bracha, S., Spagnoli, S., Russell, D. S., Stieger-Vanegas, S. M., Griffin, L., and Leeper, H., “Nasal adenocarcinoma as a suspected secondary malignant neoplasm in a cat previously treated for nasal lymphoma.”, JFMS Open Rep, vol. 6, no. 1, p. 2055116920908351, 2020.

M. Milovancev, Townsend, K. L., Tuohy, J. L., M Gorman, E., Bracha, S., Curran, K. M., and Russell, D. S., “Long-term outcomes of dogs undergoing surgical resection of mast cell tumors and soft tissue sarcomas: A prospective 2-year-long study.”, Vet Surg, 2019.

M. Milovancev, Townsend, K. L., Bracha, S., M Gorman, E., Curran, K. M., and Russell, D. S., “Reductions in margin length after excision of grade II mast cell tumors and grade I and II soft tissue sarcomas in dogs.”, Vet Surg, vol. 47, no. 1, pp. 36-43, 2018.

K. M. Curran, Bracha, S., Wong, C. P., Beaver, L. M., Stevens, J. F., and Ho, E., “Sulforaphane absorption and histone deacetylase activity following single dosing of broccoli sprout supplement in normal dogs.”, Vet Med Sci, vol. 4, no. 4, pp. 357-363, 2018.

X. Li, Schumann, C., Albarqi, H. A., Lee, C. J., Alani, A. W. G., Bracha, S., Milovancev, M., Taratula, O., and Taratula, O., “A Tumor-Activatable Theranostic Nanomedicine Platform for NIR Fluorescence-Guided Surgery and Combinatorial Phototherapy.”, Theranostics, vol. 8, no. 3, pp. 767-784, 2018.

V. M. Shah, Nguyen, D. X., Alfatease, A., Bracha, S., and Alani, A. Wg, “Characterization of pegylated and non-pegylated liposomal formulation for the delivery of hypoxia activated vinblastine-N-oxide for the treatment of solid tumors.”, J Control Release, vol. 253, pp. 37-45, 2017.

D. S. Russell, Townsend, K. L., M Gorman, E., Bracha, S., Curran, K. M., and Milovancev, M., “Characterizing Microscopical Invasion Patterns in Canine Mast Cell Tumours and Soft Tissue Sarcomas.”, J Comp Pathol, vol. 157, no. 4, pp. 231-240, 2017.

S. A. Ramsey, Xu, T., Goodall, C., Rhodes, A. C., Kashyap, A., He, J., and Bracha, S., “Cross-species analysis of the canine and human bladder cancer transcriptome and exome.”, Genes Chromosomes Cancer, vol. 56, no. 4, pp. 328-343, 2017.

R. M. Troyer, Ruby, C. E., Goodall, C. P., Yang, L., Maier, C. S., Albarqi, H. A., Brady, J. V., Bathke, K., Taratula, O., Mourich, D., and Bracha, S., “Exosomes from Osteosarcoma and normal osteoblast differ in proteomic cargo and immunomodulatory effects on T cells.”, Exp Cell Res, vol. 358, no. 2, pp. 369-376, 2017.

H. Leeper, Viall, A., Ruaux, C., and Bracha, S., “Preliminary evaluation of serum total cholesterol concentrations in dogs with osteosarcoma.”, J Small Anim Pract, vol. 58, no. 10, pp. 562-569, 2017.

M. Milovancev, Townsend, K. L., M Gorman, E., Bracha, S., Curran, K. M., and Russell, D. S., “Shaved margin histopathology and imprint cytology for assessment of excision in canine mast cell tumors and soft tissue sarcomas.”, Vet Surg, 2017.

M. Milovancev, Helfand, S. C., Marley, K., Goodall, C. P., Löhr, C. V., and Bracha, S., “Antiproliferative effects of masitinib and imatinib against canine oral fibrosarcoma in vitro.”, BMC Vet Res, vol. 12, no. 1, p. 85, 2016.

Y. Wu, Boonloed, A., Sleszynski, N., Koesdjojo, M., Armstrong, C., Bracha, S., and Remcho, V. T., “Clinical chemistry measurements with commercially available test slides on a smartphone platform: Colorimetric determination of glucose and urea.”, Clin Chim Acta, vol. 448, pp. 133-8, 2015.

R. M. Troyer, Lee, J. S., Vuyisich, M., Chain, P., Lo, C. - C., Kronmiller, B., Bracha, S., Avery, A. C., and VandeWoude, S., “First Complete Genome Sequence of Felis catus Gammaherpesvirus 1.”, Genome Announc, vol. 3, no. 6, 2015.

O. Taratula, Doddapaneni, B. S., Schumann, C., Li, X., Bracha, S., Milovancev, M., Alani, A. W. G., and Taratula, O., “Naphthalocyanine-Based Biodegradable Polymeric Nanoparticles for Image-Guided Combinatorial Phototherapy”, Chem. Mater., vol. 27, no. 17, pp. 6155–6165, 2015.

K. Marley, Bracha, S., and Séguin, B., “Osteoprotegerin activates osteosarcoma cells that co-express RANK and RANKL.”, Exp Cell Res, vol. 338, no. 1, pp. 32-8, 2015.

A. K. Viall, Goodall, C. P., Stang, B., Marley, K., Chappell, P. E., and Bracha, S., “Antagonism of serotonin receptor 1B decreases viability and promotes apoptosis in the COS canine osteosarcoma cell line.”, Vet Comp Oncol, 2014.

S. Bracha, Walshaw, R., Danton, T., Holland, S., Ruaux, C., and Obradovich, J., “Evaluation of toxicities from combined metronomic and maximal-tolerated dose chemotherapy in dogs with osteosarcoma.”, J Small Anim Pract, vol. 55, no. 7, pp. 369-74, 2014.

S. Bracha, McNamara, M., Hilgart, I., Milovancev, M., Medlock, J., Goodall, C. P., Wickramasekara, S., and Maier, C. S., “A multiplex biomarker approach for the diagnosis of transitional cell carcinoma from canine urine.”, Analytical biochemistry, vol. 455, pp. 41-7, 2014.

K. Marley, Helfand, S. C., Simpson, J., Mata, J. E., Tracewell, W. G., Brownlee, L., Bracha, S., and Séguin, B., “Pharmacokinetic study and evaluation of the safety of taurolidine for dogs with osteosarcoma.”, J Exp Clin Cancer Res, vol. 32, p. 74, 2013.